大腸がん診断テスト:医療機器パイプライン分析

◆英語タイトル:Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0191
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:439
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019″ provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 12
1.2 List of Figures 20
2 Introduction 21
2.1 Colorectal Cancer Diagnostic Tests Overview 21
3 Products under Development 22
3.1 Colorectal Cancer Diagnostic Tests – Pipeline Products by Stage of Development 22
3.2 Colorectal Cancer Diagnostic Tests – Pipeline Products by Territory 23
3.3 Colorectal Cancer Diagnostic Tests – Pipeline Products by Regulatory Path 24
3.4 Colorectal Cancer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25
3.5 Colorectal Cancer Diagnostic Tests – Ongoing Clinical Trials 26
4 Colorectal Cancer Diagnostic Tests – Pipeline Products under Development by Companies 27
4.1 Colorectal Cancer Diagnostic Tests Companies – Pipeline Products by Stage of Development 27
4.2 Colorectal Cancer Diagnostic Tests – Pipeline Products by Stage of Development 32
5 Colorectal Cancer Diagnostic Tests Companies and Product Overview 37
6 Colorectal Cancer Diagnostic Tests – Recent Developments 195
7 Appendix 427

List of Tables
Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26
Table 6: Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
Table 7: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 32
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
Table 9: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status 37
Table 10: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description 37
Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
Table 12: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status 38
Table 13: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Description 38
Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 15: Veracode - Colorectal Cancer Diagnostic Tests - Product Status 39
Table 16: Veracode - Colorectal Cancer Diagnostic Tests - Product Description 39
Table 17: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 18: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status 40
Table 19: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description 40
Table 20: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
Table 21: Cchek - Colon Cancer Confirmatory Test - Product Status 41
Table 22: Cchek - Colon Cancer Confirmatory Test - Product Description 41
Table 23: Cchek - Colon Cancer Recurrence Test - Product Status 42
Table 24: Cchek - Colon Cancer Recurrence Test - Product Description 42
Table 25: Cchek - Colon Cancer Screening Test - Product Status 42
Table 26: Cchek - Colon Cancer Screening Test - Product Description 43
Table 27: Cchek - Colon Cancer Treatment Monitoring Test - Product Status 43
Table 28: Cchek - Colon Cancer Treatment Monitoring Test - Product Description 43
Table 29: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview 44
Table 30: Cchek - Colon Cancer Screening Test - Cchek Cancer Patient Efficacy Study 45
Table 31: Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 45
Table 32: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 33: SimpliPro Colon-A - Product Status 46
Table 34: SimpliPro Colon-A - Product Description 46
Table 35: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 47
Table 36: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status 47
Table 37: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description 47
Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
Table 39: Finger Stick Test - Colon Cancer - Product Status 48
Table 40: Finger Stick Test - Colon Cancer - Product Description 48
Table 41: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 49
Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Status 49
Table 43: ArtemixRx Prognostic Test - Colon Cancer - Product Description 49
Table 44: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 45: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status 50
Table 46: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description 50
Table 47: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 48: Diagnostic Test - Colorectal Adenoma - Product Status 51
Table 49: Diagnostic Test - Colorectal Adenoma - Product Description 51
Table 50: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 52
Table 51: Idylla MSI CDx - Product Status 52
Table 52: Idylla MSI CDx - Product Description 52
Table 53: Idylla MSI Test - Product Status 53
Table 54: Idylla MSI Test - Product Description 53
Table 55: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 56: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status 54

List of Figures
Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[大腸がん診断テスト:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆